Body Systems

Psoriasis12 Results found

Studies recruiting participants:

Closed for recruitment:

Psoriasis Longitudinal Assessment and Registry (PSOLAR)

The purpose of this study is to further evaluate the safety of infliximab and ustekinumab in patients with plaque psoriasis, and other all forms of psoriasis (such as plaque psoriasis and psoriatic arthritis occurring together).

Closed for Recruitment
Principal Investigator 
Vincent C. Ho
Body Locations and Systems 
Psoriasis
Area 
Vancouver
Age 
18-99

Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in…

The purpose of this study is to demonstrate efficacy including effect on inhibition of progression of structural damage, safety and tolerability up to 2 years with primary focus at Week 24, to support the use of secukinumab pre-filled syringe (PFS) by subcutaneous (s.c.) self-administration with

Closed for Recruitment
Principal Investigator 
Jan P. Dutz
Body Locations and Systems 
Psoriasis, Psoriatic Arthritis
Area 
Vancouver
Age 
18 and above